# Neurocognitive Trajectories After BCMA CAR-T

> **NCT07740317** · — · NOT_YET_RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Myeloma (MM)
- CART Therapy
- Refractory Multiple Myeloma (RRMM)

## Interventions

- **OTHER:** Standardized neurocognitive testing

## Key facts

- **NCT ID:** NCT07740317
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740317, "Neurocognitive Trajectories After BCMA CAR-T". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07740317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*